JN  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 98: 79-85, 2007. First published May 9, 2007; doi:10.1152/jn.01103.2006
0022-3077/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/1/79    most recent
01103.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acosta, E.
Right arrow Articles by Cruzblanca, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Acosta, E.
Right arrow Articles by Cruzblanca, H.

Modulation of a Delayed-Rectifier K+ Current by Angiotensin II in Rat Sympathetic Neurons

Eduardo Acosta, Víctor Mendoza, Elena Castro and Humberto Cruzblanca

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima, Mexico

Submitted 14 October 2006; accepted in final form 5 May 2007

It is well known that angiotensin II (Angio II) mimics most of the muscarinic-mediated excitatory actions of acetylcholine on superior cervical ganglion neurons. For instance, in addition to depolarization and stimulation of norepinephrine release, muscarinic agonists and Angio II modulate the M-type K+ current and the N-type Ca2+ current. We recently found that muscarinic receptors modulate the delayed rectifier current IKV as well. Therefore a whole cell patch-clamp experiment was carried out in rat cultured sympathetic neurons to assess whether Angio II modulates IKV. We found that Angio II increased IKV by about 30% with a time constant of approximately 30 s. In comparison, inhibition of M-current was faster ({tau} ~ 8 s) and stronger (~61%). Modulation of IKV was disrupted by the AT1 receptor-antagonist losartan but not by the AT2-antagonist PD123319. IKV enhancement was reduced by the G-protein inhibitor GDP-beta-S, whereas current modulation remained unaltered after cell treatment with pertussis toxin. The peptidergic modulation of IKV was severely disrupted when internal ATP was replaced by its nonhydrolyzable analogue AMP-PNP. Angio II enhanced IKV and further reduced the stimulatory action of a muscarinic agonist on IKV. Likewise, the muscarinc agonist enhanced IKV and occluded the effect of Angio II on IKV. We have also found that the protein kinase C activator PMA enhanced IKV, thereby mimicking and further attenuating the action of Angio II on IKV. These results suggest that AT1 receptors by coupling to pertussis toxin–insensitive G proteins, stimulate an ATP-dependent and PKC-mediated pathway to modulate IKV.


Address for reprint requests and other correspondence: H. Cruzblanca, Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Av. 25 de Julio 965, Col. Villas San Sebastián, Colima, Colima 28045, Mexico (E-mail: cruzblan{at}cigc.ucol.mx)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the The American Physiological Society.